COMMUNIQUÉS West-GlobeNewswire

De nouveaux modules d’apprentissage renforcent les compétences en prescription au Canada
01/11/2018
LONDRES et OTTAWA , 01 nov. 2018 (GLOBE NEWSWIRE) -- Le Collège royal des médecins et chirurgiens du Canada (Collège royal) s’affirme une fois de plus en tant qu’ardent défenseur de la sécurité des patients canadiens en [...]
Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
01/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA) announced today that on October 26, 2018, the Compensation Committee of the Board of Directors approved, [...]
Diversicare Announces 2018 Third Quarter Results
01/11/2018
BRENTWOOD, Tenn., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR), a premier provider of long-term care services, today announced its results for the third quarter ended September [...]
Emergent BioSolutions Reports Financial Results for Third Quarter and Nine Months of 2018
01/11/2018
Q3 2018 performance in line with guidance Revises full year 2018 financial forecast to reflect anticipated strong full year organic business performance, expected at the higher end of the previous forecast, and impact [...]
IHMA annonce une nouvelle entreprise en Inde pour renforcer son soutien mondial au développement de médicaments anti-infectieux pour l'industrie biopharmaceutique
01/11/2018
SCHAUMBURG, Illinois, 01 nov. 2018 (GLOBE NEWSWIRE) -- International Health Management Associates, Inc. / IHMA Europe Sàrl (IHMA), société mondiale qui propose des services de laboratoire et de consultation à l' [...]
Agile Therapeutics Reports Third Quarter 2018 Financial Results
01/11/2018
Cash Expected to Enable Company to Fund Operations into Second Quarter 2019 PRINCETON, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported [...]
Neon Therapeutics to Host Investor Event at Society for Immunotherapy of Cancer 33rd Annual Meeting
01/11/2018
CAMBRIDGE, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that it will host an [...]
Adverum Biotechnologies Provides Program Updates
01/11/2018
Preliminary data from the ADVANCE Phase 1/2 Study in A1AT deficiency showed ADVM-043 in doses of up to 1.5 x 10 13 vg/kg were safely administered and well tolerated; Protein expression did not meet a clinically [...]
Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2018
01/11/2018
GAITHERSBURG, Md., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its third quarter 2018 financial and operating results following the close of U.S. financial markets on [...]
Pacific Biosciences of California, Inc. Announces Third Quarter 2018 Financial Results
01/11/2018
MENLO PARK, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its third quarter ended September 30, 2018. Total revenue for the third [...]
WW Announces Strong Third Quarter 2018 Results
01/11/2018
Updates Full Year 2018 Earnings Guidance End of Period Subscribers in Q3 2018 up 25% year-over-year to 4.2 million Total Paid Weeks in Q3 2018 up 24% year-over-year Revenues in Q3 2018 of $366 million, up 13%, or 14% on [...]
VIVUS Reports Third Quarter 2018 Financial Results
01/11/2018
Company to host conference call today at 4:30pm ET CAMPBELL, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ: VVUS) (the "Company"), a specialty pharmaceutical company committed to the development and [...]
Corvus Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
01/11/2018
BURLINGAME, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
BioDelivery Sciences Announces Further Significant Expanded Preferred Coverage For BELBUCA®
01/11/2018
More than 100 million Covered Lives Now Have Preferred Access to BELBUCA RALEIGH, N.C., Nov. 01, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage [...]
Equillium to Present at Investor Conferences in November 2018
01/11/2018
LA JOLLA, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory [...]
Verrica Pharmaceuticals Announces Participation in the Jefferies 2018 London Healthcare Conference
01/11/2018
WEST CHESTER, Pa., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical [...]
OncoMed Announces Third Quarter 2018 Financial Results and Operational Highlights
01/11/2018
-Company continues enrollment in Phase 1b navicixizumab trial following encouraging single agent and interim combination results in ovarian cancer; -Prepares for presentation of etigilimab data at Society for [...]
Histogenics and FDA to Continue Discussions on NeoCart Phase 3 Clinical Trial Data and Potential Regulatory Pathway
01/11/2018
WALTHAM, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored [...]
Fluidigm Announces Third Quarter 2018 Financial Results
01/11/2018
Total revenue increases 17 percent to $29.0 million Mass cytometry revenue growth of 50 percent Instrument revenue growth of 32 percent SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation [...]

Pages